NRC Health: 3 Key Takeaways for Long-Term Investors
NRC Health NRC
$26.77
β² +0.38%
(+$0.10)
Open
$26.64
Prev Close
$26.67
Day Range
$26.42 β $27.24
52W Range
$11.74 β $27.41
Market Cap
$565.98M
P/E (TTM)
96.35
Beta
0.20
Div Yield
1.16%
EPS (TTM)
$0.27
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1997-10-01 |
| Shares Out. | 21,220,000 |
| Website | nrchealth.com/ β |
| Phone | 13026587581 |
| Employees | 357 |
| Revenue | $38.4M |
| Gross Profit | $23.0M |
| Net Income | $4.7M |
| Free Cash Flow | $18.4M |
| Total Assets | $139.2M |
| Total Liabilities | $148.3M |
| Equity | -$9.1M |
About NRC Health
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
NRC Health is a publicly traded company under the ticker symbol NRC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
5 analysts (2026-11-01)
π° Latest News for NRC
National Research: Q3 Earnings Snapshot
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
National Research Corporation Q3 2026 Earnings Call Summary
NRC Health (NRC) Q3 2026 Earnings Call Transcript
National Research Q3 Earnings Call Highlights
NRC Health Announces Third Quarter 2026 Results
National Research Q3 2026 Earnings Call Transcript

